These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 19692759)

  • 1. [Role of renin-angiotensin system in prostate cancer].
    Uemura H; Kubota Y
    Gan To Kagaku Ryoho; 2009 Aug; 36(8):1228-33. PubMed ID: 19692759
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacology and new perspectives of angiotensin II receptor blocker in prostate cancer treatment.
    Uemura H; Ishiguro H; Kubota Y
    Int J Urol; 2008 Jan; 15(1):19-26. PubMed ID: 18184167
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Engagement of renin-angiotensin system in prostate cancer.
    Uemura H; Hoshino K; Kubota Y
    Curr Cancer Drug Targets; 2011 May; 11(4):442-50. PubMed ID: 21395553
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Application of angiotensin II receptor blocker in prostate cancer].
    Uemura H; Kubota Y
    Nihon Rinsho; 2009 Apr; 67(4):807-11. PubMed ID: 19348246
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiproliferative efficacy of angiotensin II receptor blockers in prostate cancer.
    Uemura H; Nakaigawa N; Ishiguro H; Kubota Y
    Curr Cancer Drug Targets; 2005 Aug; 5(5):307-23. PubMed ID: 16101380
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Angiotensin II receptor blocker: possibility of antitumor agent for prostate cancer.
    Uemura H; Ishiguro H; Kubota Y
    Mini Rev Med Chem; 2006 Jul; 6(7):835-44. PubMed ID: 16842133
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of the renin-angiotensin system in prostate cancer.
    Chow L; Rezmann L; Catt KJ; Louis WJ; Frauman AG; Nahmias C; Louis SN
    Mol Cell Endocrinol; 2009 Apr; 302(2):219-29. PubMed ID: 18824067
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Renin-angiotensin system is an important factor in hormone refractory prostate cancer.
    Uemura H; Hasumi H; Ishiguro H; Teranishi J; Miyoshi Y; Kubota Y
    Prostate; 2006 Jun; 66(8):822-30. PubMed ID: 16482568
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Angiotensin II induces oxidative stress in prostate cancer.
    Uemura H; Ishiguro H; Ishiguro Y; Hoshino K; Takahashi S; Kubota Y
    Mol Cancer Res; 2008 Feb; 6(2):250-8. PubMed ID: 18314486
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical evidence for the cardiovascular benefits of angiotensin receptor blockers.
    Nickenig G; Ostergren J; Struijker-Boudier H
    J Renin Angiotensin Aldosterone Syst; 2006 Jun; 7 Suppl 1():S1-7. PubMed ID: 16969748
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Renin-angiotensin system (RAS) as new molecular therapeutic targets in prostate cancer].
    Kubota Y; Uemura H
    Nihon Rinsho; 2012 Sep; 70(9):1604-12. PubMed ID: 23012811
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Angiotensin II up-regulates PAX2 oncogene expression and activity in prostate cancer via the angiotensin II type I receptor.
    Bose SK; Gibson W; Giri S; Nath N; Donald CD
    Prostate; 2009 Sep; 69(12):1334-42. PubMed ID: 19517575
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence for activation of the renin-angiotensin system in the human prostate: increased angiotensin II and reduced AT(1) receptor expression in benign prostatic hyperplasia.
    Dinh DT; Frauman AG; Somers GR; Ohishi M; Zhou J; Casley DJ; Johnston CI; Fabiani ME
    J Pathol; 2002 Feb; 196(2):213-9. PubMed ID: 11793373
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Angiotensin receptors in hormone-independent prostate cancer cell line DU145: presence of two variants of angiotensin type 1 receptor.
    Sidorkiewicz M; Rebas E; Szymajda M; Ławnicka H; Pawlikowski M; Lachowicz A
    Med Sci Monit; 2009 Apr; 15(4):BR106-10. PubMed ID: 19333191
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Novel molecular targeting therapeutics for prostate cancer].
    Uemura H; Nakaigawa N; Ishiguro H; Kubota Y
    Nihon Rinsho; 2005 Feb; 63(2):339-44. PubMed ID: 15714989
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Renin-angiotensin system and its role in cardiovascular physiopathology and therapy].
    Castro-Chaves P; Leite-Moreira AF
    Rev Port Cardiol; 2004 May; 23 Suppl 2():II61-77. PubMed ID: 15222251
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecule-specific effects of angiotensin II-receptor blockers independent of the renin-angiotensin system.
    Kurtz TW; Pravenec M
    Am J Hypertens; 2008 Aug; 21(8):852-9. PubMed ID: 18535538
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Appearance of angiotensin II expression in non-basal epithelial cells is an early feature of malignant change in human prostate.
    Louis SN; Wang L; Chow L; Rezmann LA; Imamura K; MacGregor DP; Casely D; Catt KJ; Frauman AG; Louis WJ
    Cancer Detect Prev; 2007; 31(5):391-5. PubMed ID: 18031950
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of the renin-angiotensin system in the regulation of erythropoiesis.
    Vlahakos DV; Marathias KP; Madias NE
    Am J Kidney Dis; 2010 Sep; 56(3):558-65. PubMed ID: 20400218
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Localization of components of the renin-angiotensin system in the suprachiasmatic nucleus of normotensive Sprague-Dawley rats: part B. angiotensin II (AT1)-receptors, a light and electron microscopic study.
    Thomas MA; Fleissner G; Stöhr M; Hauptfleisch S; Lemmer B
    Brain Res; 2004 May; 1008(2):224-35. PubMed ID: 15145760
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.